← Back to Discover
Vivo Capital, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $1,095,100,823
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- Trevi Therapeutics Inc · Common · 89532M101 · shares: $95,015,558
- Praxis Precision Medicines · Common · 74006W207 · shares: $90,766,926
- Erasca Inc · Common · 29479A108 · shares: $75,614,188
- Arrivent BioPharma Inc · Common · 04272N102 · shares: $58,436,050
- Abivax SA - ADR · SPONSORED ADS · 00370M103 · shares: $55,289,441
- Tango Therapeutics Inc · Common · 87583X109 · shares: $43,131,579
- Corvus Pharmaceuticals Inc · Common · 221015100 · shares: $41,918,891
- Bright Minds Biosciences Inc · Common · 10919W405 · shares: $39,113,474
- Sinovac Biotech Ltd. · SHS · P8696W104 · shares: $38,192,410
- Tenax Therapeutics Inc · Common · 88032L605 · shares: $36,375,000
Reported holdings
47 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| Trevi Therapeutics Inc | Common | 89532M101 | — | 5,094,668 shares | $95,015,558 |
| Praxis Precision Medicines | Common | 74006W207 | — | 271,116 shares | $90,766,926 |
| Erasca Inc | Common | 29479A108 | — | 4,127,412 shares | $75,614,188 |
| Arrivent BioPharma Inc | Common | 04272N102 | — | 1,682,097 shares | $58,436,050 |
| Abivax SA - ADR | SPONSORED ADS | 00370M103 | — | 414,899 shares | $55,289,441 |
| Tango Therapeutics Inc | Common | 87583X109 | — | 1,379,769 shares | $43,131,579 |
| Corvus Pharmaceuticals Inc | Common | 221015100 | — | 2,805,816 shares | $41,918,891 |
| Bright Minds Biosciences Inc | Common | 10919W405 | — | 557,172 shares | $39,113,474 |
| Sinovac Biotech Ltd. | SHS | P8696W104 | — | 5,903,000 shares | $38,192,410 |
| Tenax Therapeutics Inc | Common | 88032L605 | — | 2,500,000 shares | $36,375,000 |
| Aclaris Therapeutics, Inc. | Common | 00461U105 | — | 6,694,637 shares | $35,414,630 |
| Dyne Therapeutics Inc | Common | 26818M108 | — | 1,557,466 shares | $34,591,320 |
| Dianthus Therapeutics Inc | Common | 252828108 | — | 353,998 shares | $34,507,725 |
| Alto Neuroscience Inc | Common | 02157Q109 | — | 1,208,858 shares | $31,901,763 |
| DBV Technologies SA | SPONSORED ADS | 23306J309 | — | 1,844,758 shares | $30,254,031 |
| SAB Biotherapeutics Inc | Common | 78397T202 | — | 7,299,909 shares | $28,469,645 |
| Moonlake Immunotherapeutics | Class A ORD | 61559X104 | — | 1,400,000 shares | $27,258,000 |
| LB Pharmaceuticals Inc | Common | 50180M108 | — | 800,000 shares | $25,964,000 |
| Minerva Neurosciences Inc | Common | 603380205 | — | 4,322,747 shares | $23,991,246 |
| Design Therapeutics Inc | Common | 25056L103 | — | 1,612,903 shares | $23,338,706 |
| Oric Pharmaceuticals Inc | Common | 68622P109 | — | 1,848,786 shares | $20,022,352 |
| CAMP4 Therapeutics Corporation | Common | 13463J101 | — | 4,246,568 shares | $18,557,502 |
| Faeth Therapeutics Inc | Common | 81728A207 | — | 722,020 shares | $18,050,500 |
| Achieve Life Sciences Inc. | Common | 004468500 | — | 2,751,032 shares | $17,964,239 |
| Compass Therapeutics Inc | Common | 20454B104 | — | 7,757,060 shares | $16,987,961 |
| AN2 Therapeutics Inc | Common | 037326105 | — | 3,153,640 shares | $15,263,618 |
| Editas Medicine Inc | Common | 28106W103 | — | 3,555,250 shares | $11,519,010 |
| Geron Corp | Common | 374163103 | — | 8,671,797 shares | $11,099,900 |
| Odyssey Therapeutics Inc | Common | 67613T104 | — | 575,000 shares | $10,758,250 |
| Eupraxia Pharmaceuticals Inc | Common | 29842P105 | — | 1,350,000 shares | $8,923,500 |
| Onkure Therapeutics Inc | Common | 68277Q105 | — | 1,927,710 shares | $8,790,358 |
| Olema Pharmaceuticals Inc | Common | 68062P106 | — | 671,843 shares | $8,404,756 |
| Monopar Therapeutics Inc | Common | 61023L207 | — | 90,500 shares | $8,379,395 |
| Aura Biosciences Inc | Common | 05153U107 | — | 1,166,667 shares | $8,283,336 |
| Surrozen Inc | Common | 86889P208 | — | 260,000 shares | $6,747,000 |
| ALX Oncology Holdings Inc | Common | 00166B105 | — | 3,184,713 shares | $6,592,356 |
| Satellos Bioscience Inc | Common | 80401L803 | — | 813,666 shares | $6,326,253 |
| Avalo Therapeutics Inc | Common | 05338F306 | — | 275,000 shares | $5,082,000 |
| Pepgen Inc | Common | 713317105 | — | 2,325,000 shares | $4,185,000 |
| Valneva SE | SPONSORED ADS | 92025Y103 | — | 763,199 shares | $3,991,531 |
| Sera Prognostics Inc | Common | 81749D107 | — | 1,650,440 shares | $3,003,801 |
| Unicycive Therapeutics | Common | 90466Y202 | — | 550,000 shares | $2,579,500 |
| Instil Bio Inc | Common | 45783C200 | — | 292,743 shares | $2,251,194 |
| InMed Pharmaceuticals Inc | Common | 457637700 | — | 798,377 shares | $1,237,484 |
| Bolt Biotherapeutics Inc | Common | 097702203 | — | 72,414 shares | $278,794 |
| Pasithea Therapeutics Corp | Common | 70261F202 | — | 465,471 shares | $239,904 |
| Precision Biosciences Inc | Common | 74019P207 | — | 4,675 shares | $36,746 |